MLBIO Stock Overview
Manufactures and markets natural products based on organic and biodegradable substances in Italy. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Nortem BioGroup Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5.40 |
| 52 Week High | €5.40 |
| 52 Week Low | €5.40 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLBIO | FR Personal Products | FR Market | |
|---|---|---|---|
| 7D | 0% | -5.0% | -0.2% |
| 1Y | 0% | -18.5% | 2.2% |
Return vs Industry: MLBIO exceeded the French Personal Products industry which returned -21.9% over the past year.
Return vs Market: MLBIO underperformed the French Market which returned 2.7% over the past year.
Price Volatility
| MLBIO volatility | |
|---|---|
| MLBIO Average Weekly Movement | 0% |
| Personal Products Industry Average Movement | 3.4% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.9% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine MLBIO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | n/a | n/a | nortembiogroup.com |
Nortem BioGroup manufactures and markets natural products based on organic and biodegradable substances in Italy. The company provides food grade citric acid and sodium bicarbonate; Epson and Himalayan salt; spices, such as organic turmeric, ginger, and black pepper powder; and organic cocoa powder. It also offers vitamins, such as omega 3 and vitamin E food supplements, vitamin B12 food supplements, zinc and magnesium food supplements, vitamin D3 and K2 food supplements, vitamin C (ascorbic acid) powder, vitamin C (sodium ascorbate) powder, and N-acetyl cysteine food supplements.
Nortem BioGroup Fundamentals Summary
| MLBIO fundamental statistics | |
|---|---|
| Market cap | €13.92m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MLBIO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLBIO income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MLBIO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 07:14 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nortem BioGroup is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.